Company Dyadic International, Inc. Other OTC
Equities
US26745T1016
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Industrial Enzymes and Other Proteins
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -1.07% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Netherlands
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -1.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 78-12-31 |
Ping Rawson
DFI | Director of Finance/CFO | 48 | 16-05-31 |
Joseph Hazelton
COO | Chief Operating Officer | 48 | 21-11-08 |
Ronen Tchelet
CTO | Chief Tech/Sci/R&D Officer | 66 | 14-05-05 |
Doug Pace
PRN | Corporate Officer/Principal | - | 23-10-08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 78-12-31 |
Jack Kaye
BRD | Director/Board Member | 80 | 15-04-30 |
Michael Tarnok
BRD | Director/Board Member | 69 | 14-06-11 |
Patrick Lucy
CHM | Chairman | 56 | 21-01-07 |
Seth Herbst
BRD | Director/Board Member | 66 | 08-06-19 |
Barry Buckland
BRD | Director/Board Member | 76 | 18-01-02 |
Arindam Bose
BRD | Director/Board Member | 71 | 16-08-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,490,316 | 20,291,578 ( 48.91 %) | 12,253,502 ( 29.53 %) | 48.91 % |
Company contact information
Dyadic International, Inc.
1044 North US Highway One Suite 201
33477-5094, Jupiter
+
http://www.dyadic.comSector
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |